Carbidopa-levodopa in Neovascular AMD

NCT03022318 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDIV

Sponsor class

Conditions

Age-related Macular Degeneration

Interventions

DRUG: carbidopa-levodopa 25-100 mg tablets

Sponsor

Snyder, Robert W., M.D., Ph.D., P.C.